The money, trust, and people brain for companies that build in Israel and sell in dollars

The strongest Israeli companies share a shape: R&D and headcount in Israel, capital and customers in the US and EU. That means two currencies on the books, US GAAP for the board and investors, and a security posture that has to satisfy American and European buyers before a deal closes. Fintra was built for that shape, so finance, compliance, and equity live in one system instead of three tools stitched together at quarter-end.

• Defense and aerospace: programs with long timelines, milestone revenue, and buyers who demand a defensible control posture.
• Cybersecurity and AI: fast-scaling ARR, US-and-EU enterprise buyers, and AI systems that now need action-level governance of their own.
• Fintech: revenue recognition that has to be exact, plus PCI and SOC 2 pressure from the first enterprise contract.
• Biotech and pharma: grant and milestone funding, long horizons, and HIPAA exposure the moment US clinical or health data is involved.

You keep books in ILS at home and report to investors in USD. Fintra runs each entity on its own books, translates foreign currencies into your reporting currency at period-end rates, and rolls entities up into one consolidated report. On top of that sits the serious-finance layer Israeli scaleups need: full ASC 606 revenue recognition, driver-based FP&A, and spend management, all posting into the same general ledger.

For an Israeli company, compliance is not paperwork. It is the gate on every American and European enterprise contract. Fintra ships the frameworks those buyers actually ask for, with evidence that recomputes from live system state rather than a screenshot from last quarter, and with AI Action Governance so the automated actions inside your finance and ops workflows are themselves governed.

This is where Fintra is genuinely strong for Israeli startups. A typical Israeli company has US venture investors, founders and early employees in Israel, and option grants that have to satisfy US 409A valuation and ASC 718 expensing at the same time. Fintra keeps that on one cap table, models dilution across rounds, runs total compensation, and connects headcount into the workforce graph so finance and people planning share the same numbers.

• US-and-Israel cap table on one system, with US investors and Israeli holders on the same record.
• 409A valuation support and ASC 718 stock-based compensation expensing that ties back to the ledger.
• Total compensation and equity dilution modeling for offers and refresh grants.
• Global hiring and a workforce graph, so a growing Israeli-and-US team is planned as one org, not two spreadsheets.

Defense, cyber, fintech, and biotech are the verticals where Fintra’s governance and compliance depth matter most, and they are exactly the verticals Israel leads in. These are companies where a buyer will not sign without evidence, where revenue recognition has to be defensible, and where AI is increasingly taking actions that need to be governed. That is the center of what Fintra does.